Skip to main content

Genmab A/S/Genmab Finance LL

Genmab A/S is an international biotechnology enterprise headquartered in Copenhagen, Denmark, specializing in the research, development, and commercialization of innovative antibody-based therapeutics for cancer and other serious diseases. Utilizing proprietary technologies such as DuoBody and HexaBody, Genmab collaborates with global pharmaceutical partners to bring transformative medicine to patients. The company focuses on oncology, immunology, and rare disease research, maintaining a strong pipeline of clinical-stage products. Committed to pioneering therapeutic breakthroughs, Genmab operates R&D centers in Europe and North America and is listed on the Nasdaq Copenhagen and Nasdaq Global Select Market.

8 of the funds FundTelligence covers report a position in Genmab A/S/Genmab Finance LL.

Legal name
GENMAB A/S/GENMAB FINANCE LL
Sector
Health Care
Country
Denmark
Funds holding it
8

Funds holding Genmab A/S/Genmab Finance LL

Loading...